Successful Treatment of Vertebral Osteosarcoma in a Cat Using Marginal Surgical Excision and Chemotherapy

A three-year-old male neutered Norwegian Forest cat was referred for bilateral ambulatory paraparesis and spinal pain. On magnetic resonance imaging (MRI), a mass involving the right epaxial muscles with vertebral canal invasion and causing marked extradural spinal cord compression was identified. At surgery, the mass was debulked and a right hemilaminectomy was performed. Histopathology was diagnostic of fibroblastic osteosarcoma. Residual osteolytic lesions of the osteosarcoma were present at the level of the spinous process of the second lumbar vertebra. Four cycles of adjuvant doxorubicin chemotherapy were administered followed by oral toceranib phosphate. Neurological signs improved gradually over weeks to months and the lesion in the spinous process was no longer visible on radiographs. At one year from diagnosis, an MRI of the T3-L3 (3rd thoracic vertebra to the 3rd lumbar vertebra) spinal region and a whole-body computer tomography (CT) scan found no evidence of the osteosarcoma in the spine or of any metastasis. All medications were stopped and, at the time of writing 16 months later, the patient is neurologically normal with no signs of cancer recurrence. This is the first case report documenting the complete resolution of vertebral osteosarcoma lesions after treatment with doxorubicin followed by toceranib phosphate. The treatment also prevented tumor recurrence and was associated with an exceptionally long-term survival time.

[1]  A. Harper,et al.  The role of toceranib phosphate in dogs with non-mast cell neoplasia: A systematic review. , 2022, Veterinary and comparative oncology.

[2]  J. Hirschberger,et al.  Neoadjuvant therapy of locally advanced feline injection site sarcoma with thermosensitive doxorubicin-containing phosphatidyldiglycerol liposomes or free doxorubicin in combination with regional hyperthermia , 2020, Tierärztliche Praxis Ausgabe K: Kleintiere / Heimtiere.

[3]  J. Rossmeisl,et al.  Surgical decompression, with or without adjunctive therapy, for palliative treatment of primary vertebral osteosarcoma in dogs. , 2019, Veterinary and comparative oncology.

[4]  T. Yamashita,et al.  Prognosis of Primary Osteosarcoma in Elderly Patients: A Comparison between Young and Elderly Patients , 2019, Medical Principles and Practice.

[5]  M. Kiupel,et al.  The tyrosine kinase inhibitor toceranib in feline injection site sarcoma: efficacy and side effects , 2017, Veterinary and comparative oncology.

[6]  G. Polton,et al.  Neoadjuvant and adjuvant chemotherapy combined with anatomical resection of feline injection-site sarcoma: results in 21 cats. , 2016, Veterinary and comparative oncology.

[7]  Tetsuro Ohba,et al.  Pleiotropic effects of bisphosphonates on osteosarcoma. , 2014, Bone.

[8]  D. Thamm,et al.  Preliminary evidence for biologic activity of toceranib phosphate (Palladia(®)) in solid tumours. , 2012, Veterinary and comparative oncology.

[9]  D. Haines,et al.  Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor in canine cutaneous fibrosarcomas. , 2009, Journal of comparative pathology.

[10]  J. Kirpensteijn,et al.  Histologic prognosticators in feline osteosarcoma: a comparison with phenotypically similar canine osteosarcoma. , 2008, Veterinary surgery : VS.

[11]  K. Hahn,et al.  Evaluation of radiotherapy alone or in combination with doxorubicin chemotherapy for the treatment of cats with incompletely excised soft tissue sarcomas: 71 cases (1989-1999). , 2007, Journal of the American Veterinary Medical Association.

[12]  P. Shires,et al.  Surgical cytoreduction for the treatment of non-lymphoid vertebral and spinal cord neoplasms in cats: retrospective evaluation of 26 cases (1990-2005). , 2006, Veterinary and comparative oncology.

[13]  S. Withrow,et al.  Curative-intent radiation therapy as a treatment modality for appendicular and axial osteosarcoma: a preliminary retrospective evaluation of 14 dogs with the disease. , 2005, Veterinary and comparative oncology.

[14]  B. Kitchell,et al.  Primary extraskeletal hepatic osteosarcoma in a cat. , 2003, Journal of the American Veterinary Medical Association.

[15]  J. W. van der Eijken,et al.  Osteosarcoma over the age of forty. , 2003, European journal of cancer.

[16]  D. Thamm,et al.  Liposome-encapsulated doxorubicin (Doxil) and doxorubicin in the treatment of vaccine-associated sarcoma in cats. , 2002, Journal of veterinary internal medicine.

[17]  A. Bartolazzi,et al.  Extraskeletal osteosarcoma in a cat. , 2001, Journal of the American Veterinary Medical Association.

[18]  C. Wagner-Mann,et al.  Feline osteosarcoma: 145 cases (1990-1995). , 2000, Journal of the American Animal Hospital Association.

[19]  F. Shofer,et al.  Combined doxorubicin and cyclophosphamide chemotherapy for nonresectable feline fibrosarcoma. , 2000, Journal of the American Animal Hospital Association.

[20]  B. Powers,et al.  Outcome following treatment of vertebral tumors in 20 dogs (1986-1995). , 2000, Journal of the American Animal Hospital Association.

[21]  W. Rand,et al.  Prognosis for dogs with appendicular osteosarcoma treated by amputation alone: 162 cases (1978-1988). , 1992, Journal of the American Veterinary Medical Association.

[22]  H. Dorfman,et al.  Primary and secondary bone tumours in the cat. , 1974, The Journal of small animal practice.

[23]  M. Klauber,et al.  Survey of animal neoplasms in Alameda and Contra Costa Counties, California. II. Cancer morbidity in dogs and cats from Alameda County. , 1968, Journal of the National Cancer Institute.

[24]  D. Taylor,et al.  Survey of animal neoplasms in Alameda and Contra Costa Counties, California. I. Methodology and description of cases. , 1968, Journal of the National Cancer Institute.